Here at Curlew Research we are very interested in the potential offered by blockchain, also known as distributed ledger technology (DLT), to advance, enhance and disrupt healthcare – from candidate drug discovery to the medicines supply chain. One area that seems to us ripe for the marriage of DLT and healthcare is genomics – specifically […]